Hydatid disease is a public health problem in endemic areas. Although it is most commonly present in the liver and lung, it rarely affects other tissues. A 62-year-old female patient was admitted to our outpatient clinic with a palpable, moderately mobile mass over the thoracic spine. On MRI, a cystic lesion, hypointense and hyperintense on T1-and T2-weighted scans, respectively, was detected. During surgery, a well capsulated cyst was excised en bloc. On histological examination, a hydatid cyst was diagnosed. Her postoperative serological test was positive. Her whole body was scanned for any other organ involvement, but scans were all negative. She was treated with albendazol. After 3 months, the test result was negative, and there were no local or systemic recurrences. Primary subcutaneous tissue involvement is a rarely reported entity in the literature. To the best of our knowledge, this is the first case report of a primary subcutaneous hydatid cyst detected over the thoracic spine. (Turkiye Parazitol Derg 2014; 38: 264-9) Keywords: Echinococcus, hydatid cyst, magnetic resonance imaging, surgery Received: 21.05.2013
INTRODUCTION
Human hydatid disease is caused by infection with the larval stage of taeniid cestodes of Echinococcus (1) (2) (3) . There are six known species, as follows: E. granulosus (cystic echinococcosis), E. multilocularis (alveolar echinococcosis), E. vogeli, and E. oligarthrus (polycystic echinococcosis), but four species are a public health concern (1-3). E. granulosus is the most frequent cause of the disease (4) . It is a public health problem in endemic areas (temperate zones such as Central Asia, China, Central and Southern parts of former Soviet Union, Australia, southern South America, the whole Mediterranean zone, the Middle East, parts of Africa) (1-3).
Hydatid disease mainly involves the liver and lung, but may secondarily affect other organs. Primary involvement of other organs is a known but rare clinical entity; thus, in such a case, diagnosis may be delayed, and it may lead to complications. In this report, we describe a case of hydatid disease in an unusual location.
CASE REPORT
A 62-year-old woman was admitted to our outpatient clinic with a palpable mass over her thoracic spine. She had been having pain for 5 months before the lesion appeared. She lived in an animal farm in a rural site 30 years previously. She had no prior history of trauma, fever, or weight loss. Her physical examination was unremarkable, except for the palpable, moderately mobile mass over the thoracic spine. Routine laboratory findings were within normal limits, except her anemia. Erythrocyte sedimentation rate and C-reactive protein level were normal. Her neurological examination was nonspecific. On thoracic magnetic resonance (MR) imaging, the lesion was hypointense and hyperintense on T1-and T2-weighted images, respectively, with a hypointense rim on both scans (Figure 1a-d) . After IV gadolinium application, the lesion was enhanced (Figure 1e, f) . The patient was operated on, and the cystic mass was totally excised ( Figure  2a ) and measured 3×2.5×4 cm. Before closure, the cavity was scrubbed with povidone-iodine solution. Pathological diagnosis was a hydatid cyst (E. granulosus) (Figure 2b, c) . The patient was referred to an infectious disease specialist. The indirect hemagglutination test was positive for Echinococcus antigen at 1/512 dilution. Imaging studies [central nervous system MR imaging, PA chest radiography, abdominal ultrasonography (USG)] were negative for other possible locations for the disease. She was given a 3-month trial of albendazole 400 mg twice daily and evaluated every 2 weeks with complete blood count (CBC) and liver function tests. After 3 months, her serological test became negative, and albendazole was stopped. There were neither local nor systemic recurrences.
DISCUSSION
Echinococcus granulosus is a cestode (1) . Its intermediate hosts are wild and domestic ungulates, and its definitive hosts are canids (1, 3, 5) . Humans are an accidental intermediate host (5) . The hydatid cyst is a unilocular, fluid-filled cyst and is composed of two compartments: inner germinal layer and outer acellular acidophilic-staining laminated membrane (1, 5) . With time, the germinal layer produces brood capsules, leading to the appearance of daughter cysts (1).
Humans are infected directly with parasite eggs released in definitive hosts' feces or indirectly by contamination via water, food, or arthropods. Eggs release embryos in the small intestine. Embryos penetrate the bowel wall and pass to the liver via blood (1, 3, 5) . In our case, there were no other sites of infection other than subcutaneous tissue. This might have occurred by dissemination through the lymphatic system, bypassing the liver (3, 5) . In the viscera, embryos develop into a cystic structure. In most human infections, a single cyst is detected, but in 20-40% of patients, multiple cysts or multiple organ involvement are detected (1, 5) . In adults, the most commonly infected organ is the liver (>65%), and the second most commonly infected organ is the lung (25%) (1, 4) . The cyst is less common in other organs such as the central nervous system, heart, bone (1-4%), spleen (<2%), pancreas (0.2-2%), peritoneal cavity (13%), kidney (3%), adrenal gland, ovary, breast, omentum, retroperitoneum, mediastinum, muscles, pelvic organs, and salivary glands (1-4). Subcutaneous involvement is usually reported to be caused by iatrogenic spillage of cyst contents to the subcutaneous tissue (2) . Primary subcutaneous involvement is a rare entity in the literature (incidence: 0.2-2%) (3, 6) . The most common location reported in the literature is the thigh (27%) (2, 3, (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . The main presenting complaint is a slowly growing mass just under the intact skin (6) . In the English literature, to the best of our knowledge, this is the first case report of thoracic primary subcutaneous hydatid disease. There has been only one case of recurrence against all therapy methods applied (Table 1) The hydatid cyst enlarges progressively; thus, the clinical symptoms and signs may appear according to tolerability of the organ involved. In patients with the infected liver and lung, it presents at a later stage, while in patients with brain or eye involvement, it is usually detected at an early stage (1) . Clinical manifestations differ according to the cyst size, location, and condition of the cyst itself (1, 3) . Nevertheless, above all these, rupture of the cyst may cause allergic reactions independent of the involvement site (1) . Hydatid disease has a mortality rate of 4% (4).
In endemic areas, differential diagnosis should include hydatid disease in the presence of cystic lesions. Other diseases included in differential diagnosis are abscesses, hematomas, mycoses, benign cysts, benign or malignant neoplasms, tuberculosis, and aneurysms (1-3) . Radiological assessment combined with immunohistochemical techniques helps in making correct diagnosis (1) (2) (3) (4) . MR imaging, computed tomography (CT) scan, USG, and sometimes plain radiography are valuable radiologic tools for assessment of cysts in all organs (1) (2) (3) (4) (5) . Special radiologic properties include cyst wall calcification, daughter cyst, and detached germinal membrane (2, 4) . MR imaging is superior to others for cutaneous imaging (2) . A pathology-based classification with radiological correlation has been described by Lewall in 1998 (5) . The classification is summarized in Table 2 . The cyst in our case had a unilocular appearance without daughter cysts, representing a type I cyst.
ELISA and indirect hemagglutination are useful tests for serum screening (1, 3) . In our case, after histopathologic diagnosis of the hydatid cyst, the indirect hemagglutination test was positive (at 1/512 dilution). It is important to remember that intact, unruptured cysts do not release proteins and do not cause immuno- Surgery with total resection, if applicable, is the main therapy. During resection, the wall should be kept intact. If not, dissemination of the disease and anaphylaxis may occur. Endocystectomy, pericystectomy, marsupialization, capitonage, simple drainage of the cyst, and resection of the infected organ are surgical methods used in daily practice (1, 2, 5) . Pregnancy, multiple cysts, unsuitable medical condition, and patient's avoidance are main contraindications for surgery. In such circumstances, puncture, aspiration, injection, reaspiration (PAIR) and medical treatment are methods of choice (1, 5) . After 1980s, benzimidazole compounds were introduced. Their efficiency has been confirmed by many clinical trials (1) . A complete cure can be achieved in one-third of patients. In considerable percent of patients (30-50%), regression of cyst size is achieved (1). Albendazole (10-15 mg/kg/day) is a better drug than mebendazole (40-50 mg/kg/day) because of its pharmacokinetic properties. Minimal treatment period is 3 months. In our case, after diagnosis, the patient used albendazole for 3 months. Serological test became negative, and treatment was stopped with ongoing outpatient follow-ups.
CONCLUSION
Diagnosis of hydatid disease in organs other than the liver or lung sometimes is not straightforward and causes delay in treatment. In endemic areas, hydatid disease should be taken into consideration for differential diagnosis when a cystic lesion is identified in any organ of the body. In cases of primary subcutaneous hydatid disease, en bloc resection is the treatment of choice. After resection, treatment with benzimidazole regimens is mandatory to prevent recurrences.
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